MicroRNAs and Drug Resistance in Prostate Cancers
Author:
Affiliation:
1. Department of Pharmaceutical Sciences, School of Pharmacy, Hampton University, Hampton, Virginia 23668, United States
2. Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/mp500099g
Reference165 articles.
1. National Cancer Institute. Prostate Cancer. http://www.cancer.gov/cancertopics/types/prostate.
2. Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer
3. A retrospective study of the time to clinical endpoints for advanced prostate cancer
4. 2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MicroRNAs in Genitourinary Malignancies: An Exciting Frontier of Cancer Diagnostics and Therapeutics;International Journal of Molecular Sciences;2024-08-31
2. Cuproptosis: Mechanism, role, and advances in urological malignancies;Medicinal Research Reviews;2024-02
3. Androgen receptor-dependent mechanisms mediating therapy resistance in prostate cancer;Therapy Resistance in Prostate Cancer;2024
4. Role of exosomes in prostate cancer and male fertility;Drug Discovery Today;2023-11
5. In Vivo Stem Cell Discoveries: Promising Implications in Cancer Therapy;Journal of Lab Animal Research;2023-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3